HOME >> BIOLOGY >> NEWS
'Defensive' action by influenza viruses demonstrated by Hebrew university researcher

Combating viruses is often a frustrating business. Find a way to destroy them --- and before you know it, they've found a way to defend themselves and neutralize the anti-viral treatment.

How, exactly, do the viruses do it? In an article published as the cover story in a recent issue of the journal Proteins, a Hebrew University of Jerusalem researcher, Prof. Isaiah (Shy) T. Arkin, has revealed just how influenza-causing viruses adapt to nullify the effectiveness of the anti-viral drug symmetrel (generic name).

The revelation can have significant consequences in leading drug researchers to develop new and more effective means to block influenza and other viruses in the future.

Influenza, Prof. Arkin emphasizes, is a major killer, even though many people tend to shrug it off as an unpleasant seasonal nuisance. In the U.S. it is the leading cause of death from infectious diseases, claiming about 40,000 lives annually, mostly among the elderly.

In his research, Arkin, of the Department of Biological Chemistry at the Hebrew University's Silberman Institute of Life Sciences, has demonstrated how flu viruses counteract the symmetrel drug. Assisting him in his work were graduate students Peleg Astrahan and Itamar Kass, as well as Dr. Matt Cooper from Cambridge University in Britain.

Administered at an early stage at the onset of flu symptoms, symmetrel is intended to destroy the virus by binding to and blocking a proton-conducting channel which the virus needs in order to continue functioning and multiplying.

Rather than conceding defeat, however, the virus takes its own counteractions: either by narrowing its channel to the extent that the blocking element in the drug is unable to bind and create a seal, or by widening its channel so that the blocker can get in, but can't totally seal the channel. Arkin notes that the latter action is the more surprising and unexpected one.

While counteraction of the virus to t
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-588-1904
The Hebrew University of Jerusalem
5-Sep-2004


Page: 1 2

Related biology news :

1. DNA lends scientists a hand, revealing new chemical reactions
2. Charting the future in prostate cancer care: A call to action
3. Long-term effects of carbon monoxide poisoning are an autoimmune reaction
4. Common call for action on European Research Council (ERC)
5. New technique helps scientists reveal interactions between genes and drugs
6. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
7. Rutgers chemist uses NMR to elucidate protein-DNA interaction
8. Findings suggest need for new view of p53 cancer proteins interaction with DNA
9. A pregnant pause for unexpected interactions
10. Infusion of two peptides acts to accelerate appetite satisfaction
11. Chemical reaction in birds provides sense of direction during migratory flights

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/1/2020)... ... April 30, 2020 , ... ... Siemens Healthineers and several healthcare VC firms announces an official launch of CareDoctors.com. ... is to enhance patient care experience by offering live video consultations with board ...
(Date:5/1/2020)... SEATTLE (PRWEB) , ... April 30, 2020 , ... ... for emerging infectious diseases, announced today that it had been awarded a contract ... of the Assistant Secretary for Preparedness and Response at the U.S. Department of ...
(Date:4/30/2020)... ... April 28, 2020 , ... Pebble Labs USA ... challenges in agriculture and aquaculture with the mission of improving global food security, announced ... F&A Next ' Next Heroes in Food- and Ag-Tech ' virtual event, a global ...
Breaking Biology News(10 mins):
(Date:4/26/2020)... ... April 23, 2020 , ... ... today, an online store providing applications and services for use on Microsoft Azure. ... business needs to sign up online for a built-for-purpose customer engagement capability to ...
(Date:4/22/2020)... ... April 20, 2020 , ... ... MA, announced today that Omixon’s founder and chairman Dr. Attila Berces returns as ... product Holotype HLA since 2014 before stepping into the CEO role in 2017. ...
(Date:4/22/2020)... ... April 21, 2020 , ... Ripple Science ... Many clinical trial teams are working remotely and have paused patient visits, forcing ... researchers continue their research during this uncertain time by giving research teams free ...
(Date:4/7/2020)... (PRWEB) , ... April 06, 2020 , ... Gateway ... future children, reached 200,000 SneakPeek Early Gender DNA Tests sold in March, ... was launched as an ecommerce product, where a mom could order her kit ...
Breaking Biology Technology:
Cached News: